Felice E. Brit v. Aegis Senior Communities LLC, No. 88460-3

Washington Court of Appeals Division I issued an opinion in Brit v. Aegis Senior Communities LLC on April 27, 2026, affirming, reversing, or remanding a judgment from June 25, 2025. The case, docket 88460-3, involves Felice E. Brit as respondent and Aegis Senior Communities LLC as appellant, with the opinion authored by Judge Lori Smith and concurrence by Judges David Mann and Bill Bowman.

Danielle Gray v. City of Seattle, 27th Apr

The Washington State Court of Appeals Division I affirmed the judgment of the trial court in favor of the City of Seattle and Seattle Office of Housing. The opinion was filed on April 27, 2026, authored by Judge Lori Smith with concurrences from Bill Bowman and David Mann. The appellant Danielle Gray appeared pro se. The judgment or order under review was originally filed on August 1, 2025.

Humber Bridge Barrier Safety Improvement Scheme £6M Tender

The Humber Bridge Board has published an open tender for the Barrier Safety Improvement Scheme (BSIS), a design and build contract (NEC4 ECC) valued at £5,000,000 excluding VAT (£6,000,000 including VAT). The scope comprises design and installation of approximately 5 km of footpath parapet height extension across the suspension bridge, Barton South Approach Viaduct, and abutting anchorage sections, plus replacement of 8 life-expired footpath expansion joints at Hessle and Barton Towers. The contract runs from 29 June 2026 to 30 August 2027. Tenders are due by 3 June 2026 at 12:00pm.

Ceredigion County Council PV Panel Maintenance £78,257

Ceredigion County Council has awarded a contract valued at £78,257.38 including VAT to Will Davey Electrical for annual inspection and cleaning of photovoltaic (PV) panels across council sites. The contract runs for three years from 5 May 2026 to 5 May 2029 and covers works across South West Wales (UKL14). The procurement was conducted as a below-threshold open competition procedure under the Procurement Act 2023. This is a routine contract award notice and does not create compliance obligations for third parties.

Post Office Awards Q5 Ltd £642k Target Operating Model Contract

Post Office Limited has awarded a direct award contract to Q5 Ltd for services establishing Target Operating Model (TOM) guardianship, planning development, and programme leadership. The contract is valued at £535,000 excluding VAT (£642,000 including VAT), above the relevant procurement threshold. The estimated contract period runs from 8 May 2026 through 31 July 2026 (approximately 2 months and 24 days), with an award decision date of 22 April 2026.

Space Technology Solutions - BOXXE LIMITED Added to Supplier Roster

BOXXE LIMITED has been added as an approved supplier to the Government Commercial Agency's Space Technology Solutions dynamic market roster under the Procurement Act 2023. The addition covers 35 procurement categories spanning ground infrastructure, sensors, unmanned autonomous vehicles, SATCOM, software services, and data analytics including AI. BOXXE LIMITED is registered at Floor 3, Artemis House, York, YO31 7RE, and joins the roster effective 27 April 2026.

Space Technology Solutions Awarded to SPACEFLUX LTD

SPACEFLUX LTD was added as a supplier to the Space Technology Solutions dynamic market modification notice under the Procurement Act 2023. The modification was published on 27 April 2026, adding the company to Parts 101-240 and Parts 301-425 covering ground stations, satellite components, cryptographic technology, PNT services, SATCOM, UxV technology, and associated services. The contracting authority is the Government Commercial Agency, a central government body.

Shropshire Council £285k Lift Maintenance Tender

Shropshire Council has published a tender for lift maintenance services valued at £285,000 (including VAT), estimated to run from 1 August 2026 to 31 July 2031 with a possible extension to 31 July 2033. The contract requires a fully comprehensive lift service including repairs, rescue services for lift entrapment situations, call handling management, and SAFed Supplementary tests. Tender submissions close on 27 May 2026 at 12:00pm via the delta-esourcing portal.

West Midlands Ambulance £191,680 Ortivus UK Contract

West Midlands Ambulance Service University NHS Foundation Trust has awarded a £191,680 contract for an Electronic Controlled Drugs System (COT system) to Ortivus UK LTD. The contract was awarded on 1 April 2026 following a pre-market review conducted because time was of the essence. Ortivus UK LTD, confirmed as an SME, is the sole contractor for this supplies contract covering software to manage the movement of controlled drugs within the Trust.

West Midlands Ambulance Service NHS FT Awards £374,444 F5 Network Contract to Softcat PLC

West Midlands Ambulance Service University NHS Foundation Trust has awarded a contract for F5 Network equipment and services to Softcat PLC, valued at £374,444 excluding VAT. The procurement was justified without prior publication of a call for competition on the grounds that time was of the essence as a capital end-of-year purchase. The contract was awarded on 4 February 2026 following receipt of three tenders, all from SMEs and all submitted electronically. The contract is not covered by the Government Procurement Agreement.

West Midlands Ambulance SQL Server Contract to Softcat, £114,484

West Midlands Ambulance Service University NHS FT has awarded a £114,484 contract for SQL Server Software Assurance to Softcat PLC, with the contract effective from 1 March 2026. The procurement was conducted via a below-threshold quotes process using sellers, attracting three bids all from SMEs, and was published on 27 April 2026. This is a routine contract award notice with no further obligations for other parties.

Post Office Awards TOM Services Contract to Q5 LTD for £535k

Post Office Limited has awarded a direct-award contract to Q5 LTD for establishing Target Operating Model (TOM) guardianship, planning development, and programme leadership services. The contract is valued at £535,000 excluding VAT (£642,000 including VAT), running from 8 May 2026 to 31 July 2026. The direct award justification cites extreme and unavoidable urgency requiring no delay in beginning critical TOM programme work.

Honey Bee Venom Immunotherapy Randomised Safety Study, Victoria

The Royal Melbourne Hospital has registered a Phase 0 randomised controlled pilot study comparing two honey bee venom immunotherapy (HBV-VIT) initiation strategies in adults sensitised to honey bee venom. The trial will enrol 24 participants at The Royal Women's Hospital (Parkville) and Monash Medical Centre (Clayton), Victoria, with anticipated first enrolment on 30 April 2026 and final data collection by 30 July 2027. Participants will be randomised to either direct 100-µg maintenance-dose initiation (weeks 0, 4, 8, 12) or ultrarush up-dosing (escalating doses over six weeks), with safety monitoring for systemic and local reactions across the 12-week induction period. The study aims to quantify immunologic changes (HBV-specific sIgE/sIgG4), blood tryptase, late-phase symptoms, and quality-of-life outcomes.

Osteopathy Versus Physiotherapy for Chronic Low Back Pain, Warsaw Poland

ANZCTR registration ACTRN12626000521325 for a completed comparative effectiveness trial conducted entirely in Warsaw, Poland, comparing osteopathic manual therapy versus conventional physiotherapy for non-specific chronic lumbosacral pain. The trial enrolled 84 participants (target 102), was approved by the Bioethics Committee of the Medical University of Warsaw on 15/04/2014, and was retrospectively registered on 28/04/2026 after data collection concluded on 25/02/2022. No individual participant data will be shared as the survey was conducted anonymously.

Deadly Fit Mums Exercise Program for Indigenous Mothers

The Deadly Fit Mums (DFM) program is an Aboriginal community-led exercise and nutrition education program registered as a clinical trial on ANZCTR (ACTRN12626000522314). The program serves pregnant and post-partum women birthing an Aboriginal and Torres Strait Islander baby through the Birthing in Our Community (BiOC) service across four sites in South East Queensland. The primary sponsor is Federica Barzi at the University of Queensland, with the Institute for Urban Indigenous Health as a collaborator and funding from the Australian Government Department of Health Medical Research Future Fund. Ethics approval was granted by The University of Queensland Human Research Ethics Committee (2025/HE000966) on 18/06/2025. The trial is registered retrospectively with enrollment of 1,300 participants completed between January 2023 and June 2025, and final data collection anticipated by June 2026.

Telco Complaints Data Highlights Wait Times and Escalations

The ACMA's quarterly Telecommunications Consumer Complaints report for October-December 2025 shows Australian telcos averaged 5.9 days to resolve customer complaints, up from 5.7 days in the prior quarter. Among major telcos, TPG Telecom resolved complaints in 4 days on average, Optus in 6 days, and Telstra in 8 days, while Vonex was slowest at 22 days. The report also tracks complaints per 10,000 services and escalation rates to the Telecommunications Industry Ombudsman, with the overall TIO referral ratio rising to 7.3 percent. The ACMA notes it is closely monitoring complaint levels across different technology types, and telcos remain bound by ACMA's complaint handling standard.

UK Statement at UN General Assembly on NPT Review Conference

The UK, through Minister of State Stephen Doughty MP, delivered a statement at the UN General Assembly NPT Review Conference reaffirming its commitment to the Treaty on the Non-Proliferation of Nuclear Weapons (NPT) and Article VI obligations. The statement expressed concern over Russia's invasion of Ukraine, Iran's non-compliance with safeguards, DPRK's nuclear weapons development, and China's nuclear arsenal expansion. The UK committed to supporting IAEA safeguards, the P5 Process, fissile material cut-off treaty negotiations, and its civil nuclear expansion programme including Small Modular Reactors.

Sovereign AI Co-Invests with British Business Bank in Ineffable Intelligence

The UK government, through its Sovereign AI Fund administered by the Department for Science, Innovation and Technology, is co-investing with the British Business Bank in Ineffable Intelligence, a UK-founded AI company developing self-learning algorithms capable of discovering new knowledge through experience rather than processing existing human data. The company was founded by Professor David Silver, formerly Head of Reinforcement Learning at Google DeepMind and creator of AlphaGo. This investment brings the total number of companies backed by the Sovereign AI Fund to 8 since its launch.

UK Urges International Action to Safeguard Maritime Security at UN Security Council

The United Kingdom, through Minister of State Stephen Doughty MP, delivered a statement at the UN Security Council calling for renewed international action to safeguard international waterways from disruption, with particular focus on the Strait of Hormuz crisis. The UK stated that Iran must not hold the global economy hostage and called for the Strait to be reopened fully and unconditionally, freedom of navigation to be restored, and shipping and seafarers not to be used as leverage. The UK welcomed Resolution 2817, which condemned Iran's attacks against regional neighbours and disruption of international trade, while noting that Russia and China vetoed a further resolution protecting navigational rights and freedoms.

Right to Buy Overhaul to Safeguard Social Housing

The UK government has confirmed it will bring forward further Right to Buy reforms including increasing the minimum eligibility period from three to ten years, amending discount rules to start at 5% increasing by 1% each year up to a maximum of 15%, and introducing a 35-year new build exemption period. These measures aim to help councils better protect and rebuild depleted social housing stock. The changes will be brought forward when Parliamentary time allows.

FSS Korea Deploys AI Surveillance for Illegal Financial Influencer Monitoring

FSS Korea has deployed an AI-based real-time surveillance system operating 24/365 to monitor illegal financial influencer activities. Analysis linking AI data with reports and market intelligence identified three categories of violations: impersonation of financial influencers by illegal financial investment operators, investment fraud by impersonators of financial companies, and operation of illegal reading rooms after channel acquisition. FSS Korea plans a public awareness campaign through KBS, MBC, and CBS radio stations starting May 1, 2026, for three to four weeks.

금융투자업계 장애인 고용 활성화 간담회 개최

금융감독원과 금융투자협회는 고용노동부, 한국장애인고용공단과 함께 2026년 4월 28일 금융투자업계 장애인 고용 활성화를 위한 간담회를 개최했다. 증권사 22개사와 자산운용사 9개사가 참석하여 장애인 고용 확대 지원제도를 안내받고 금융투자업계의 우수사례를 공유했다. 이번 간담회는 지난 2026년 3월 6일 체결된 금융권 장애인 고용확대를 위한 업무협약의 후속 조치로 마련되었다.

FSS Korea Launches KakaoTalk Channel for Financial Education

FSS Korea has launched a KakaoTalk channel for its Financial Education Center (registered April 28, 2026), enabling consumers to access financial education programs, event information, and lifecycle-specific content directly through the messaging platform. The channel will host interactive events and collect user feedback to improve educational effectiveness. A channel-opening event runs for three weeks starting April 28, with prizes awarded to 100 randomly selected participants.

FSS Korea Signs MOU with Regional Financial Holdings to Strengthen External Directors

FSS Korea Governor Lee Chan-jin signed an MOU on April 28, 2026 with regional financial holding companies including iM Financial Holdings, BNK Financial Holdings, and JB Financial Holdings to enhance the training and competency of external directors. The signing ceremony was held at the Banking Hall from 09:30 to 10:00, with representatives from the Korean Bankers Association and the Korea Financial Training Institute also in attendance. The FSS noted that a prior MOU with five major holdings signed in February 2025 has already increased training program participation from 33 participants in 2024 to 384 in 2025.

Electronic Payment Fee Disclosure Status, 18 Companies, Apr 2026

FSS Korea published the disclosure status for 18 electronic financial service operators covering September 2025 through February 2026, showing average card fee rates of 1.98% and prepaid fee rates of 1.74%. The disclosure guidelines, introduced in March 2023 on a semi-annual basis, were expanded in November 2025 to enhance effectiveness by adding more companies and disclosure items to the reporting scheme.

Enhanced Executive Compensation Disclosure for Listed Companies

FSS Korea has revised corporate disclosure forms to strengthen executive compensation transparency for listed companies. Effective May 1, 2026, companies must disclose compensation-performance linkage by reporting total and per-person average compensation alongside operating profit and total shareholder return (TSR). Stock-based compensation must be separately itemized, and the disclosure lookback period expands to three years with income-type breakdowns required. Semi-annual reports for December fiscal year companies will be the first to use the new format. FSS Korea plans to review disclosures and require self-correction for inadequate filings.

FSS Korea Announces Expansion of Mid-Interest Rate Loans to Promote Inclusive Finance

FSS Korea and the Financial Services Commission announced measures to expand mid-interest rate loans at lower rates to promote inclusive finance. Sajitdol loans target near-prime borrowers with reformed eligibility criteria, new individual business owner categories, and expanded supply channels, aiming for 3.6 trillion won in 2026 with rate reductions up to 5.2 percentage points. Private mid-interest rate loans improve interest calculation formulas and expand supply channels, targeting 28.3 trillion won+α with rate reductions up to 1.25 percentage points. These measures align with National Agenda Item 59 on strengthening inclusive finance for low-income and vulnerable populations.

FSS Korea Expands Car Insurance Fraud Audio Alert Service to 100 Regions and 3 Navigation Apps

FSS Korea is expanding its voice alert service warning drivers of deliberate car accident fraud-prone areas, scaling coverage from 35 to 100 regions and adding Naver Maps (길찾기) as a third integrated navigation app alongside T Map and Kakao Navigation. The enhanced service now initiates audio alerts at 150 meters before entering a designated zone and adds popup notifications identifying the most frequent accident type in each area. Built-in navigation systems from Hyundai Motor Company and Kia are planned for integration by mid-2026, eliminating the need for separate app installation.

Sofidel America Corp. Pays $80,000 in EEOC Sex Discrimination and Retaliation Settlement

The U.S. Equal Employment Opportunity Commission (EEOC) resolved a sex discrimination and retaliation lawsuit against Sofidel America Corp., a manufacturer of paper products, for $80,000. The company also agreed to provide training, revise its policies, and monitor future complaints as part of the settlement. The claims involved discrimination based on sex and unlawful retaliation under Title VII of the Civil Rights Act of 1964. Employers should note that EEOC settlements often include systemic compliance terms beyond monetary relief, signaling the agency's continued focus on workplace discrimination enforcement.

Skills, Safety & Needs Research Project Results Presented in Milan

INAIL presented the final results of the 'Skills, Safety & Needs – Health and Safety at Work in the Education and Training System' research project (BRiC 2022, ID34) at Università Cattolica del Sacro Cuore in Milan. The national-scale study combined document analysis, interviews, and surveys of school administrators, teachers, and students to examine safety training needs in technical and vocational education institutions. Key recommendations advocate integrating occupational safety as a structural educational dimension rather than a purely compliance-driven exercise.

Arbitrary Code Execution Vulnerability in Nessus, CVE-2026-33694

The Centre for Cybersecurity Belgium published a critical security warning on 27 April 2026 for CVE-2026-33694, a vulnerability affecting Nessus Agent <= 11.1.2 and Nessus <= 10.11.3 on Windows systems. The flaw, rated CVSS 7.4, allows an authenticated attacker to delete arbitrary files with SYSTEM privileges and potentially execute arbitrary code with elevated privileges. The CCB strongly recommends installing updates with the highest priority after thorough testing, and advises organisations to upscale monitoring and detection capabilities to identify suspicious activity.

Critical Arbitrary Code Execution Vulnerability CVE-2026-41635 in Apache MINA

The Centre for Cybersecurity Belgium issued a critical advisory warning of CVE-2026-41635, a CVSS 9.8 arbitrary code execution vulnerability in Apache MINA versions 2.0.0 through 2.0.27, 2.1.0 through 2.1.10, and 2.2.0 through 2.2.5. The vulnerability exists in the AbstractIoBuffer.resolveClass() method where one code path bypasses classname allowlist validation, enabling attackers to achieve arbitrary code execution through the IoBuffer.getObject() function. Organizations using affected Apache MINA instances are urged to patch immediately, with fully compromised systems at risk of data exfiltration and lateral movement to interconnected systems.

Fannie Mae Schedules Q1 2026 Financial Results Webcast for April 29, 8:00 AM ET

Fannie Mae will release its first quarter 2026 financial results on Wednesday, April 29, 2026, before U.S. market open. Acting CEO and COO Peter Akwaboah and CFO Chryssa C. Halley will host a webcast at 8:00 a.m. ET the same day to discuss results. Prior to the webcast, the company will post its Q1 2026 news release, Form 10-Q, earnings presentation, and supplemental materials to its Quarterly and Annual Results webpage. A transcript will be published after the event and remain available for approximately one year.

Effect of Spinal and General Anesthesia on Frontal QRS Axis in Total Knee Arthroplasty

NIH registered study NCT07551648, a prospective observational trial comparing frontal QRS axis changes in patients undergoing total knee arthroplasty under spinal versus general anesthesia. The study will enroll adults aged 18 years and older with ASA physical status I to III, using standard 12-lead electrocardiography to measure preoperative-to-postoperative QRS axis changes. Enrollment criteria, methodology, and outcome measures are now publicly available on ClinicalTrials.gov for research transparency purposes.

Pilot Validation of STELA Digital Preventive Medicine Platform for Cardiovascular Risk Reduction in Adults

A pilot validation study for the STELA digital preventive medicine platform has been registered on ClinicalTrials.gov (NCT07551960) by researchers at AGEL Hospital Trinec-Podlesi in Czechia. The platform is designed to identify, quantify, and reduce modifiable cardiovascular health risk factors in adults without established cardiovascular disease through comprehensive health assessments, personalized prevention plans, and coordinated wellness interventions. The study uses the AGEL Gamification Index scoring system and involves participants undergoing extensive baseline assessments including laboratory panels, physical tests, and imaging studies.

Novel MRI Sequences for Prostate Cancer Diagnosis Accuracy: NCT07552285

NCT07552285 is a prospective observational study registered at a single center evaluating the diagnostic efficacy and grading accuracy of novel MRI sequences (MAGiC, OGSE, CEST, IVIM) for prostate cancer detection. The study enrolls patients with clinical suspicion of prostate cancer and performs both conventional and new sequence magnetic resonance scans, using surgical or biopsy pathological results as the gold standard for comparison. The primary research question is whether novel non-contrast multiparametric MRI imaging can improve accuracy of prostate cancer diagnosis and grading compared to conventional approaches.

Goserelin Preserves Ovarian Function in Aplastic Anemia Following Allogeneic HSCT

This ClinicalTrials.gov registration documents NCT07552506, a prospective randomized multicenter clinical trial investigating whether Goserelin prophylaxis preserves ovarian function in 132 female patients aged 14-50 with severe aplastic anemia undergoing allogeneic hematopoietic stem cell transplantation. Patients will be stratified by busulfan conditioning status and randomized 1:1 to receive a single 3.6 mg subcutaneous Goserelin injection 1-3 days prior to conditioning or standard transplantation regimen without Goserelin. The primary endpoint is menstrual recovery rate at 6 months post-transplant, defined as at least 3 naturally occurring menstrual cycles without intervention by menstrual-regulating drugs.

Astragalus Membranaceus 480mg/day 10-Week Muscle Function Study NCT07552675

This double-blind, placebo-controlled, randomized clinical trial (NCT07552675) evaluated whether daily supplementation with Astragali radix extract (480 mg/day) for 10 weeks could attenuate training-induced impairments in muscle function, joint pain, and inflammatory markers in moderately active young adults during 8 weeks of progressive resistance training followed by 2 weeks of intensified training. Participants were randomized to receive either the herbal extract or placebo, with primary outcome measured as maximal voluntary isometric torque (MVIT) of the knee extensors and secondary outcomes including 1RM strength, knee range of motion, muscle soreness, and circulating biomarkers of muscle damage and inflammation. The study record was processed and made publicly available on ClinicalTrials.gov.

Trapeziometacarpal Joint Arthroplasty Versus Trapeziectomy for Thumb Carpometacarpal Osteoarthritis RCT

Sahlgrenska University Hospital in Gothenburg, Sweden has registered a single-centre, blinded randomized controlled trial comparing trapeziometacarpal prosthetic arthroplasty versus trapeziectomy for symptomatic thumb carpometacarpal osteoarthritis in adults aged 18-69 years with Eaton grade 2-3 disease refractory to 3 months of non-operative treatment. The target enrollment is 64 participants randomized 1:1, with primary outcome of day-by-day pain measured on a numeric rating scale (NRS 0-10) and follow-up extending to 10 years.

CABG Trial Comparing Radial Artery vs No-Touch Vein Graft in Women

A randomized controlled trial comparing outcomes of coronary artery bypass grafting (CABG) in women at 1 year post-surgery has been registered on ClinicalTrials.gov under identifier NCT07552948. The main group includes 55 patients receiving CABG with radial artery grafts, while the control group includes 55 patients receiving CABG with great saphenous vein prepared using the no-touch technique, both for revascularization of the circumflex artery. The study examines the condition of coronary artery atherosclerosis.

Adapted RPM-08 for Substance Use Disorder in Pakistan

This ClinicalTrials.gov registration (NCT07552623) describes an eight-week randomized controlled trial in Pakistan testing whether a culturally adapted Relapse Prevention Module (RPM-08) combined with usual treatment reduces relapse risk in adults with substance use disorders, compared to usual treatment alone. Participants will attend eight structured group sessions and complete questionnaires at baseline, post-intervention, and follow-up to assess whether the adapted intervention's effects are sustained over time. This trial registration provides study design and participant information but does not impose compliance obligations on regulated entities.

Clinical Performance of Laryseal Clear vs Ambu Aura40 Laryngeal Mask Airway for Preschool Children

A clinical trial comparing the performance of Laryseal Clear and Ambu Aura40 laryngeal mask airways in preschool children undergoing surgical procedures has been registered on ClinicalTrials.gov. The study will evaluate both devices as supraglottic airway devices in pediatric anesthesia settings. NCT07553247 was registered on April 27, 2026, and the trial will assign participants to either the LarySeal clear Group or the Ambu Aura40 Group.

Low Intensity Laser Therapy Study, Children, Pneumonia

Clinical trial NCT07552116 registered on ClinicalTrials.gov evaluates whether low intensity laser therapy combined with standard medical treatment improves immune response in children with Down syndrome (DS) and pneumonia. The randomized controlled study enrolled 40 DS children with bronchopneumonia, assigning 20 to receive low intensity laser therapy three times weekly for one month alongside inspiratory muscle training and medical treatment. Both groups had immune system markers (WBCs, IgG, IgA, IgM), respiratory rate, and oxygen saturation measured before and after the one-month treatment period.

SECP Proposes IBAN, Biometric Verification for Digital Investor Onboarding

SECP has proposed amendments to the AML/CFT/CPF Regulations, 2020 introducing IBAN-based verification through SECP-notified entities including NCCPL via RAAST as valid proof of identity, mandatory use of verified bank accounts or e-wallets for investor transactions, and multi-biometric verification including facial recognition aligned with NADRA systems. Regulated Persons will continue to bear full responsibility for KYC, due diligence, transaction monitoring, and AML compliance. The draft amendments are open for public consultation for 14 days.

Pakistan Capital Market Resilient Despite Global Shock in Q3 FY2026

SECP's Q3 FY2025-26 Quarterly Market Review found Pakistan's KSE-100 declined 14.54% amid global market volatility driven by the US-Iran conflict, rising oil prices, and broad risk-off sentiment. Despite this, domestic institutional and retail investors fully absorbed PKR 111.61 billion in foreign outflows, while three IPOs were approved and GoP Ijara Sukuk auctions attracted bids of PKR 2.03 trillion against an PKR 800 billion target. SECP attributed market resilience to strong domestic participation, continued primary market activity, and regulatory reforms.

RxPreferred Benefits LLC Consent Order A-2584

The Nebraska Department of Insurance entered a Consent Order against RxPreferred Benefits LLC on April 17, 2026. The order, designated Cause Number A-2584, addresses regulatory violations identified through departmental proceedings. The company has agreed to the terms specified in the consent order. Compliance obligations and any associated penalties are documented in the full order PDF maintained by the department.

DOS Proposes Single 38-Page U.S. Passport Book, Seeks Comments

The U.S. Department of State is seeking public comments on a proposal to consolidate its passport book offerings from two sizes (26-page and 50-page) to a single 38-page book as part of the Series B redesign anticipated for 2028. Currently, 92 percent of passport applicants request the 26-page book, while 8 percent receive the 50-page book, with special-issuance and overseas applicants accounting for most 50-page issuances. The change is expected to increase efficiencies and reduce waste in production at the Government Publishing Office and in the issuance process at the Department of State. Comments must be submitted by June 22, 2026.